+44 (0) 1223 755950
+1 832 327 7413
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)
REQUEST MORE INFO
Catalogue No: abx620093
Price:
US$290.00
(Size: 50 µg)
Orders to United States ship from United States
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant) is a recombinant protein expressed in E. coli.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein (Omicron B.1.1.529 Variant)
| Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein (Omicron B.1.1.529 Variant) |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | SDS-PAGE |
| Host | E. coli |
| Purity | > 90% (SDS-PAGE) |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| NCBI Accession | UFO69279.1 |
| Molecular Weight | Calculated MW: 46.31 kDa |
| Sequence Fragment | Met1-Ala419 |
| Tag | N-terminal His tag |
| Buffer | Prior to lyophilization: PBS, pH 7.5, 0.02 % NLS, 1mM EDTA, 4 % Trehalose, 1 % Mannitol |
| Standard Form | A DNA sequence encoding the SARS-CoV-2 Nucleocapsid (YP_009724397.2, with mutations P13L, ERS31-33 deletion, R203K, G204R) (Met1-Ala419) was expressed with a polyhistidine tag at the N-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |